Mass Spectrometry and Peptide Identity Confirmation in the Lab

HPLC can tell you a sample is one clean peak. It cannot tell you what that peak is. Mass spectrometry peptide identity confirmation fills that gap by measuring the mass-to-charge ratio of ions made from the sample and comparing it with the value predicted from the sequence. This article explains how peptide ions are generated, how to read charge states and isotope patterns, what tandem MS adds, and how the method has been used to settle what a product called TB-500 actually contains.

Getting a peptide into the gas phase

Peptides are polar, non-volatile and fragile, so the ionization step has to be gentle. Two soft ionization techniques dominate.

Electrospray ionization (ESI) sprays a solution through a charged capillary. As droplets shrink, intact analyte ions are released into the gas phase, typically carrying several protons. The 1989 paper that set out ESI for large biomolecules described exactly this property: multiple charging brings large molecules into an m/z range that ordinary analysers can measure [1]. ESI couples naturally to liquid chromatography, which is why LC-MS is the standard pairing in peptide QC.

Matrix-assisted laser desorption/ionization (MALDI) co-crystallizes the peptide with a UV-absorbing matrix and desorbs it with a laser pulse. MALDI spectra are dominated by singly charged [M+H]+ ions, which makes them easy to read at a glance, and a time-of-flight (TOF) analyser gives a fast molecular-weight check.

Either route is acceptable on a certificate of analysis, provided the observed ion is reported and matches the expected value.

Reading a peptide mass spectrum

Three concepts cover most of what you need.

Charge states. An ESI spectrum lists m/z, not mass. A peptide of mass M carrying z protons appears at (M + z x 1.007) / z. A 3 kDa peptide may show its strongest signal at [M+3H]3+ near m/z 1000. Recognising a charge-state series is the first step in reading any ESI spectrum.

Isotope envelope. Natural 13C means every peptide appears as a cluster of peaks. The spacing between them reveals the charge: 1.0 m/z units apart for a 1+ ion, 0.5 for 2+, 0.33 for 3+. On high-resolution instruments this is the most reliable way to assign charge.

Monoisotopic versus average mass. For small peptides at good resolution, compare the observed monoisotopic peak with the calculated monoisotopic mass. Low-resolution data, or very large molecules, will sit closer to the average mass. A CoA should state which one it reports.

What tandem MS adds

A matching intact mass is strong evidence, but not proof. A peptide with two residues swapped has the same mass as the correct sequence. Tandem mass spectrometry (MS/MS) isolates the precursor ion and fragments it, most often by collision-induced dissociation, which cleaves peptide bonds along the backbone. Fragments containing the N-terminus are called b ions; those containing the C-terminus are y ions. Mass differences between consecutive b or y ions correspond to individual residues, so the spectrum can be read as a sequence ladder [2].

For routine QC, full MS/MS sequencing is not always performed. Single-quadrupole detectors on UHPLC systems give intact mass for every chromatographic peak, which lets an analyst assign impurities (a deletion is lighter by one residue mass, an oxidized methionine heavier by 16 Da) without reference standards [5]. That combination of retention time plus mass is what makes LC-MS so efficient for peptide quality work.

Worked example: what "TB-500" contains

The name TB-500 has circulated without a formal chemical definition, and it is sometimes used loosely for full-length thymosin beta-4, a 43-residue protein of roughly 4.9 kDa. Analytical chemistry resolved the question for the commercial material. Using LC with high-resolution Orbitrap mass spectrometry, a doping-control laboratory identified the N-terminally acetylated 17-23 fragment of thymosin beta-4, Ac-LKKTETQ, in a TB-500 preparation and confirmed it against a reference made by solid-phase synthesis [3]. A second group described the same acetylated heptapeptide as the key ingredient and developed an LC-MS method for it and its metabolites, the latter first identified from in-vitro incubations [4]. The LKKTETQ segment corresponds to the actin-binding region of thymosin beta-4 [4].

That gives clear targets for identity testing of TB-500:

Quantity	Ac-LKKTETQ value
Formula	C38H68N10O14
Monoisotopic mass	888.49 Da
Average mass	889.0 Da
[M+H]+	m/z 889.50
[M+2H]2+	m/z 445.25
[M+3H]3+	m/z 297.17
y1 fragment (Gln)	m/z 147.08

A spectrum showing an [M+2H]2+ ion at 445.25 with 0.5-unit isotope spacing is consistent with the heptapeptide. A cluster of highly charged ions pointing to a mass near 4.9 kDa would indicate full-length thymosin beta-4 instead. The two are different molecules, and a CoA should make clear which one is in the vial.

Pitfalls in mass spectrometry peptide identity checks

• Reporting "conforms" without numbers. The observed m/z and the assigned charge state should both be shown.
• Adducts misread as impurities. Sodium (+22 Da relative to [M+H]+) and potassium (+38 Da) adducts are common and are not separate species.
• Missing a modification. N-terminal acetylation adds 42.01 Da and C-terminal amidation subtracts 0.98 Da. Both change the expected mass and must be in the calculation.
• Isomers. D-amino acid substitutions and sequence scrambles share a mass with the target. Retention time and MS/MS help here.

A 2015 quality study of research peptides found one sample whose main component had a different structure from the peptide ordered [6]. A mass check against the correct theoretical value is the most direct way to catch that kind of error, which is why our lab reports include the spectrum rather than a pass/fail line.

How identity and purity fit together

Mass spectrometry and HPLC answer different questions and belong on the same page. HPLC gives the proportion of the UV signal in the main peak; MS confirms the main peak's identity and can name the impurities around it. Our overview of HPLC purity testing explains the chromatographic half, and how to read a certificate of analysis shows how the two appear together on a CoA. If you want to know where deletion and adduct impurities come from in the first place, see solid-phase peptide synthesis.

Key takeaways

• ESI and MALDI are soft ionization methods that keep peptides intact for mass measurement.
• Read ESI spectra by charge state and isotope spacing, and compare monoisotopic values at high resolution.
• Tandem MS produces b and y ion ladders that confirm sequence order, which intact mass alone cannot.
• Published doping-control work identifies TB-500 as Ac-LKKTETQ (888.49 Da monoisotopic), distinct from full-length thymosin beta-4.
• A credible identity report shows the observed m/z, charge state and theoretical value.

This article summarizes published research for informational purposes. All Ascent Sciences products are for laboratory research use only and are not for human or animal consumption.

References

1. Fenn JB, Mann M, Meng CK, et al. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246(4926):64-71. PubMed
2. Steen H, Mann M. The ABC's (and XYZ's) of peptide sequencing. Nat Rev Mol Cell Biol. 2004;5(9):699-711. PubMed
3. Esposito S, Deventer K, Goeman J, et al. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. Drug Test Anal. 2012;4(9):733-738. PubMed
4. Ho EN, Kwok WH, Lau MY, et al. Doping control analysis of TB-500, a synthetic version of an active region of thymosin beta4, in equine urine and plasma by liquid chromatography-mass spectrometry. J Chromatogr A. 2012;1265:57-69. PubMed
5. D'Hondt M, Gevaert B, Wynendaele E, et al. Implementation of a single quad MS detector in routine QC analysis of peptide drugs. J Pharm Anal. 2016;6(1):24-31. PubMed
6. Verbeke F, Wynendaele E, Braet S, et al. Quality evaluation of synthetic quorum sensing peptides used in R&D. J Pharm Anal. 2015;5(3):169-181. PubMed